The Discounted Cash Flow (DCF) valuation of Corline Biomedical AB (CLBIO.ST) is (1,098.97) SEK. With the latest stock price at 8.28 SEK, the upside of Corline Biomedical AB based on DCF is -13372.6%.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| WACC / Discount Rate | 5.1% - 6.5% | 5.8% |
| Long-term Growth Rate | 3.0% - 4.4% | 3.7% |
| Fair Price | (3,514.97) - (655.20) | (1,098.97) |
| Upside | -42551.3% - -8013.1% | -13372.6% |